The FMD is now a legal requirement and a full update was provided at the MHRA conference in December. The focus on API audits and GDP were discussed as was the requirement for excipient GMP. Both these activities are placing demands on pharmaceutical manufacturers and will continue to be a focus for the MHRA Inspectors.
The conference also saw communication of the new Orange guides (EU GMP guide) and this includes the recently updated GDP guide. At 600+ pages and a cost of £60+ it is a must for all MIA and WDA holders as well as QPs and RPs.
The 21st Pharmig conference had a record attendance with in excess of 70 delegates, 25 exhibitors plus committee members and international speakers. The conference was very well received. It was my last as chair of Pharmig and a great way to end my tenure. I was very humbled to be made an honorary member of Pharmig and received a great send off from the committee, friends and colleagues. I will continue to support Pharmig and there is the PCT event on 13th February 2014, plus I will be hosting a water meeting in March 2014.
Please let me know if MQAS can be of service to you or your company and contact me via the web site or LinkedIn
